John Shishido

John is responsible for developing and executing corporate strategy, identifying new business models, and building commercial partnerships to accelerate the advancement of BPGbio’s clinical-stage assets.

Prior to BPGbio he led strategy and investments for Innova Medical Group and was a Principal at Pasaca Capital. Before joining Pasaca he advised clients in the Technology and Precision Biology sectors on M&A and capital formation at Citigroup. He began his career as an aerospace engineer. John received his MBA from UCLA and his bachelor’s and master’s degrees in engineering from USC.